• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Acute Leukemias: Pharmacokinetics and Management of Relapsed and Refractory Disease

Acute Leukemias: Pharmacokinetics and Management of Relapsed and Refractory Disease

Paperback

Series: Haematology and Blood Transfusion Hämatologie Und Bluttransf, Book 34

Medical Reference

ISBN10: 3540539492
ISBN13: 9783540539490
Publisher: Springer
Published: Feb 25 1992
Pages: 670
Weight: 2.12
Height: 1.40 Width: 6.14 Depth: 9.21
Language: English
Following the major breakthroughs in the and frequent and thorough exchange of treatment of acute leukemias in the seven- information. Hence, it was felt that a spe- ties by the introduction of intensive combi- cial series of symposia should be devoted to nation regimens, therapeutic progress has Pharmacokinetics and Management of slowed down and the impression of stagna- Relapsed and Refractory Disease comple- menting the established meetings on Prog- tion may even have occured. In contrast, the knowledge about the biology of leu- nostic Factors and Treatment Strategies kemias is rapidly expanding and allows new which will proceed in parallel. It was the insights into the pathophysiology of the aim of the international symposium disease. Further improvements also come ACUTE LEUKEMIAS - Pharmacokine- from a better understanding of the pharma- tics and Management of Relapsed and cokinetics and pharmacodynamics of cyto- Refractory Disease to provide an update static drugs and their mechanisms of action. of the present knowledge in this area and to Hence, novel treatment modalities can be stimulate further developments. As a sign developed on a more solid basis and ration- for the closing distance between countries al. These achievements need to be comple- and the development of effective world- mented by effective eradiation wide cooperation this symposium emerged of residual disease or its permanent control and new from the joint efforts of the German AML approaches have been derived from recent Cooperative Group and the M. D.

Also in

Medical Reference